
Sign up to save your podcasts
Or


We discuss the 12 month results of the Phase I Davio Trial of an innovative TKI agent for the sustained treatment of neovascular AMD with Dr. Rishi Singh, Professor of Ophthalmology, Cole Eye Insitute, President, Cleveland Cllinic-Martin Hospital, Stuart, Florida.
By Retina Synthesis4.5
88 ratings
We discuss the 12 month results of the Phase I Davio Trial of an innovative TKI agent for the sustained treatment of neovascular AMD with Dr. Rishi Singh, Professor of Ophthalmology, Cole Eye Insitute, President, Cleveland Cllinic-Martin Hospital, Stuart, Florida.

43 Listeners

18 Listeners

99 Listeners

113,168 Listeners

56,921 Listeners

5 Listeners

9,558 Listeners

12 Listeners

47,696 Listeners

51 Listeners

11 Listeners

467 Listeners

19 Listeners

0 Listeners